Debt to Equity Ratio Analysis of BioCryst Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY Debt to Equity
Period Ending - Dec-23
Poor Debt to Equity
2.35
Period Ending - Dec-22
Very Poor Debt to Equity
-0.506
Growth
565.50 %
Most recent Quarter Debt to Equity
Period Ending - Mar-24
Poor Debt to Equity
2.42
Debt to Equity Analysis of BioCryst Pharmaceuticals Inc
| Debt to Equity Ratio of BCRX rose handsomely by 565.50 % this year. |
| Debt to Equity Ratio of BCRX trending up for at least three Years. |
| Debt to Equity Ratio with value of -7.83 was lowest in Year Dec-20 in last Five Years. |
| Latest Debt to Equity Ratio with value of 2.35 is Greater than Average Debt to Equity of -1.87 in last five years. |
Other Debt to Equity Related Info of BCRX that may interest you.
BioCryst Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| BCRX | 6.24 | 6.17 | 1.13 % | Biotechnology |
Defination of Debt to Equity Ratio
Debt to Equity Ratio shows the relationship between the company's total debt and total shareholders fund. And it indicates the ability of a company's shareholders' equity to pay its debt obligations in a tough time. more ..
Debt to Equity Related Ratios
| ShortTermDebtToEquityRatio | DividendCoverageRatio | CurrentRatio |
Tsr Stability Index
| Poor Stability Stock | |
FY - Historical Debt to Equity Ratio of BioCryst Pharmaceuticals Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| Debt to Equity | 2.35 | -0.506 | -5.49 | -7.83 | 2.12 | 1.20 | 0.620 |
| Change | 565.50 % | 90.79 % | 29.94 % | -468.87 % | 76.89 % | 93.54 % | -98.08 % |
FY Chart of Debt to Equity Ratio of BioCryst Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)